204 related articles for article (PubMed ID: 22122788)
1. Modern management of primary B-cell immunodeficiencies.
Hoernes M; Seger R; Reichenbach J
Pediatr Allergy Immunol; 2011 Dec; 22(8):758-69. PubMed ID: 22122788
[TBL] [Abstract][Full Text] [Related]
2. Hypogammaglobulinaemia.
Yong PF; Chee R; Grimbacher B
Immunol Allergy Clin North Am; 2008 Nov; 28(4):691-713, vii. PubMed ID: 18940570
[TBL] [Abstract][Full Text] [Related]
3. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency.
Alachkar H; Taubenheim N; Haeney MR; Durandy A; Arkwright PD
Clin Immunol; 2006 Sep; 120(3):310-8. PubMed ID: 16782407
[TBL] [Abstract][Full Text] [Related]
4. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
[TBL] [Abstract][Full Text] [Related]
5. Modern management of primary T-cell immunodeficiencies.
Pachlopnik Schmid J; Güngör T; Seger R
Pediatr Allergy Immunol; 2014 Jun; 25(4):300-13. PubMed ID: 24383740
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success.
Durandy A; Wahn V; Petteway S; Gelfand EW
Int Arch Allergy Immunol; 2005 Mar; 136(3):217-29. PubMed ID: 15713984
[TBL] [Abstract][Full Text] [Related]
7. Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.
Berger M
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):532-8. PubMed ID: 21971330
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
[TBL] [Abstract][Full Text] [Related]
9. Genetic syndromic immunodeficiencies with antibody defects.
Ming JE; Stiehm ER
Immunol Allergy Clin North Am; 2008 Nov; 28(4):715-36, vii. PubMed ID: 18940571
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency.
Picard C; Fischer A
Immunol Allergy Clin North Am; 2010 May; 30(2):173-8. PubMed ID: 20493394
[TBL] [Abstract][Full Text] [Related]
11. Primary immunodeficiencies.
Notarangelo LD
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S182-94. PubMed ID: 20042228
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
13. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
[TBL] [Abstract][Full Text] [Related]
14. Primary immunodeficiencies.
Cooper MA; Pommering TL; Korányi K
Am Fam Physician; 2003 Nov; 68(10):2001-8. PubMed ID: 14655810
[TBL] [Abstract][Full Text] [Related]
15. Primary immunodeficiency: a never ending story.
Etzioni A; Fuleihan R
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):503-4. PubMed ID: 21971336
[No Abstract] [Full Text] [Related]
16. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B
J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379
[No Abstract] [Full Text] [Related]
17. Immunoglobulin treatment in primary antibody deficiency.
Maarschalk-Ellerbroek LJ; Hoepelman IM; Ellerbroek PM
Int J Antimicrob Agents; 2011 May; 37(5):396-404. PubMed ID: 21276714
[TBL] [Abstract][Full Text] [Related]
18. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
[TBL] [Abstract][Full Text] [Related]
19. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
20. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.
Yong PL; Boyle J; Ballow M; Boyle M; Berger M; Bleesing J; Bonilla FA; Chinen J; Cunninghamm-Rundles C; Fuleihan R; Nelson L; Wasserman RL; Williams KC; Orange JS
Clin Immunol; 2010 May; 135(2):255-63. PubMed ID: 19914873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
